| Model Number |
DTMB1QQ |
| Medical Device Problem Codes |
Failure to Deliver Shock/Stimulation (1133); Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Device Sensing Problem (2917)
|
| Health Effect - Clinical Codes |
Tachycardia (2095); Shock from Patient Lead(s) (3162)
|
| Date of Event |
03/15/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Product event summary: the device was returned and analyzed.Analysis of the device revealed normal battery depletion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Continuation of d10: 1688t lead implanted: (b)(6) 2006.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient received possible inappropriate anti-tachycardia pacing (atp) and high voltage therapy for supra ve ntricular tachycardia (svt) that was detected by the cardiac resynchronization therapy defibrillator (crt-d) as fast ventricular tachycardia (fvt).It was also reported that there was possible inappropriately withheld therapy for fvt episodes which were classified as svt.The crt-d was explanted and replaced two days later due to reaching recommended replacement time (rrt).No further patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was confirmed, via follow up, that the patient received inappropriate therapy for atrial fibrillation (af) with rapid ventricular response.
|
| |
|
Search Alerts/Recalls
|